Search Results - "Rantapää Dahlqvist, S"

Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006 by Holmqvist, M. E., Wedrén, S., Jacobsson, L. T. H., Klareskog, L., Nyberg, F., Rantapää‐Dahlqvist, S., Alfredsson, L., Askling, J.

“…  Holmqvist ME, Wedrén S, Jacobsson LTH, Klareskog L, Nyberg F, Rantapää‐Dahlqvist S, Alfredsson L, Askling J (Institute of Environmental Medicine, Karolinska…”
Get full text

Individuals at risk of seropositive rheumatoid arthritis: the evolving story by Rantapää Dahlqvist, S., Andrade, F.

“…The aetiology of the autoimmune disease rheumatoid arthritis (RA) involves a complex interplay between genetic and environmental factors that initiate many…”
Get full text

Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study by Bengtsson, C, Öhman, M-L, Nived, O, Dahlqvist, S Rantapää

“…Introduction. An increased rate of cardiovascular disease (CVD) has been suggested in patients with systemic lupus erythematosus (SLE). The risk for myocardial…”
Get full text

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register by Askling, J, Baecklund, E, Granath, F, Geborek, P, Fored, M, Backlin, C, Bertilsson, L, Cöster, L, Jacobsson, L T, Lindblad, S, Lysholm, J, Rantapää-Dahlqvist, S, Saxne, T, van Vollenhoven, R, Klareskog, L, Feltelius, N

“…Tumour necrosis factor (TNF) antagonists have proved effective as treatment against rheumatoid arthritis (RA), but the unresolved issue of whether the use of…”
Get more information

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists by Askling, J, Fored, C M, Brandt, L, Baecklund, E, Bertilsson, L, Feltelius, N, Cöster, L, Geborek, P, Jacobsson, L T, Lindblad, S, Lysholm, J, Rantapää-Dahlqvist, S, Saxne, T, Klareskog, L

“…Background: Existing studies of solid cancers in rheumatoid arthritis (RA) reflect cancer morbidity up until the early 1990s in prevalent cohorts admitted to…”
Get full text

Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006-2011 by Ziegelasch, M, Boman, A, Martinsson, K, Thyberg, I, Jacobs, C, Nyhäll-Wåhlin, BM, Svärd, A, Berglin, E, Rantapää-Dahlqvist, S, Skogh, T, Kastbom, A

“…Objective: The discovery of anti-citrullinated protein antibodies (ACPAs) and the introduction of new therapeutic options have had profound impacts on early…”
Get full text

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists by Askling, J, Fored, C M, Baecklund, E, Brandt, L, Backlin, C, Ekbom, A, Sundström, C, Bertilsson, L, Cöster, L, Geborek, P, Jacobsson, L T, Lindblad, S, Lysholm, J, Rantapää-Dahlqvist, S, Saxne, T, Klareskog, L, Feltelius, N

“…Background: Patients with rheumatoid arthritis (RA) are at increased risk of malignant lymphomas, and maybe also of leukaemia and multiple myeloma. The effect…”
Get full text

Association of Valine and Leucine at HLA–DRB1 Position 11 With Radiographic Progression in Rheumatoid Arthritis, Independent of the Shared Epitope Alleles but Not Independent of Anti–Citrullinated Protein Antibodies by Steenbergen, H. W., Raychaudhuri, S., Rodríguez‐Rodríguez, L., Rantapää‐Dahlqvist, S., Berglin, E., Toes, R. E. M., Huizinga, T. W. J., Fernández‐Gutiérrez, B., Gregersen, P. K., Helm‐van Mil, A. H. M.

“…Objective For decades it has been known that the HLA–DRB1 shared epitope (SE) alleles are associated with an increased risk of development and progression of…”
Get full text

Does a Genetic Variant in FOXO3A Predict a Milder Course of Rheumatoid Arthritis? by Steenbergen, H. W., Rantapää‐Dahlqvist, S., Nies, J. A. B., Berglin, E., Huizinga, T. W. J., Gregersen, P. K., Helm‐van Mil, A. H. M.

Get full text

Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation by Alenius, G M, Berglin, E, Rantapää Dahlqvist, S

“…Objective: To compare the prevalence of anti-CCP antibodies in psoriatic patients with and without joint inflammation, patients with early RA, and controls…”
Get full text

Cytokine mRNA Profile of Alveolar T Lymphocytes and Macrophages in Patients with Systemic Sclerosis Suggests a Local Tr1 Response by Andersen, G. N., Nilsson, K., Nagaeva, O., Rantapää‐Dahlqvist, S., Sandström, T., Mincheva‐Nilsson, L.

“…The development of an autoimmune disease like systemic sclerosis (SSc) is suspected to be driven by an activated T lymphocyte subset, expressing a cytokine…”
Get full text

Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy by Dahlqvist, S. Rantapää, Engstrand, S., Berglin, E., Johnson, O

“…Objectives: To analyse the effects of infliximab infusions on serum levels of lipids in patients with rheumatoid arthritis (RA) treated for 2 years. Methods:…”
Get full text

Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis by Rantapää-Dahlqvist, S.

“…A positive rheumatoid factor (RF) test has been included as one of the criteria for the diagnosis of rheumatoid arthritis (RA) according to the 1987…”
Get full text

Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept by Feltelius, N, Fored, C M, Blomqvist, P, Bertilsson, L, Geborek, P, Jacobsson, L T, Lindblad, S, Lysholm, J, Rantapää-Dahlqvist, S, Saxne, T, Klareskog, L

“…Objectives: To describe a nationwide system for postmarketing follow up of new antirheumatic drugs in Sweden, and to analyse safety and effectiveness in an…”
Get full text

The R620W C T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1 by Reddy, M V Prasad Linga, Johansson, M, Sturfelt, G, Jönsen, A, Gunnarsson, I, Svenungsson, E, Rantapää-Dahlqvist, S, Alarcón-Riquelme, M E

“…The gene PTPN22 is located on chromosome 1p13 and encodes a protein tyrosine phosphatase called the lymphoid-specific phosphatase (Lyp). Lyp is expressed in…”
Get full text

Systemic lupus erythematosus and cardiac risk factors: medical record documentation and patient adherence by Bengtsson, C, Bengtsson, AA, Costenbader, KH, Jönsen, A, Rantapää-Dahlqvist, S, Sturfelt, G, Nived, O

“…This study explores patients’ knowledge of cardiac risk factors (CRFs), analyses how information and advice about CRFs are documented in clinical practice, and…”
Get full text

Secretory antibodies to citrullinated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first‐degree relatives by Svärd, A., Roos Ljungberg, K., Brink, M., Martinsson, K., Sjöwall, C., Rantapää Dahlqvist, S., Kastbom, A.

“…Summary The aim of this study was to evaluate secretory antibodies to citrullinated proteins (ACPA) in plasma and immunoglobulin (Ig)A ACPA in saliva from…”
Get full text

Antibody response to the human stress protein BiP in rheumatoid arthritis by Bodman-Smith, M. D., Corrigall, V. M., Berglin, E., Cornell, H. R., Tzioufas, A. G., Mavragani, C. P., Chan, C., Rantapää-Dahlqvist, S., Panayi, G. S.

“…Objectives. The human stress protein BiP (immunoglobulin binding protein) has been implicated in the pathogenesis of rheumatoid arthritis (RA) since BiP was…”
Get full text

Increased levels of autoantibodies against copper‐oxidized low density lipoprotein, malondialdehyde‐modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis by Cvetkovic, J. T., Wållberg‐Jonsson, S., Ahmed, E., Rantapää‐Dahlqvist, S., Lefvert, A. K.

“…Objectives. To analyse the association of autoantibodies against cardiolipin (CL) and oxidized low density lipoproteins [copper‐oxidized low density…”
Get full text

Are Neuropeptides Important in Arthritis? by GRIMSHOLM, O., GUO, YZ, NY, T., RANTAPÄÄ-DAHLQVIST, S., FORSGREN, S.

“…:  Interference with the effects of neuropeptides may be of potential therapeutic value for the treatment of rheumatoid arthritis (RA). Two neuropeptides that…”
Get full text